Welcome to CDC stacks | Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination - 14350 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination
  • Published Date:
    Nov 2003
  • Source:
    Emerg Infect Dis. 9(11):1468-1470.
Filetype[PDF-156.02 KB]


Details:
No Related Documents.
You May Also Like:
  1. Antibody Inhibition of a Viral Type 1 Interferon Decoy Receptor Cures a Viral Disease by Restoring Interferon Signaling in the Liver
    Personal Author:
    Xu, Ren-Huan; Rubio, Daniel; Roscoe, Felicia; Krouse, Tracy E.; Truckenmiller, Mary Ellen; Norbury, Christopher C.; Hudson, Paul N.; Damon, Inger K.; Alcamí, Antonio; Sigal, Luis J.;
    Published:
    Jan 05 2012
    Source:
    PLoS Pathog. 2012; 8(1).
    Description:
    Type 1 interferons (T1-IFNs) play a major role in antiviral defense, but when or how they protect during infections that spread through the lympho-hematogenous route is not known. Orthopoxviruses, including those that produce smallpox and mousepox, s...
    File Type:
    Filetype[PDF - 1.84 MB]
  2. Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18
    Personal Author:
    Zhao, Li; Liu, Binlei; Ren, Jiao; Feng, Jing; Pang, Zheng; Gao, Jian; Zhang, Hui; Tan, Wenjie; Tian, Houwen; Ruan, Li;
    Published:
    Jun 15 2011
    Source:
    Virol J. 2011; 8:302.
    Description:
    Background : Persistent infection with high-risk human papillomavirus (HPV) is a predominant cause of cervical cancer, and HPV16 and HPV18 occur in 50% and 20% of cervical cancer cases, respectively. The viral oncogenes E6 and E7 are constitutively e...
    File Type:
    Filetype[PDF - 1.11 MB]
  3. Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
    Personal Author:
    Kim, Jin Hyang; Reber, Adrian J.; Kumar, Amrita; Ramos, Patricia; Sica, Gabriel; Music, Nedzad; Guo, Zhu; Mishina, Margarita; Stevens, James; York, Ian A.; Jacob, Joshy; Sambhara, Suryaprakash;
    Published:
    Nov 16 2016
    Source:
    Sci Rep. 2016; 6.
    Description:
    The association of seasonal trivalent influenza vaccine (TIV) with increased infection by 2009 pandemic H1N1 (A(H1N1)pdm09) virus, initially observed in Canada, has elicited numerous investigations on the possibility of vaccine-associated enhanced di...
    File Type:
    Filetype[PDF - 1.76 MB]
  4. T Cell Chemo-Vaccination Effects after Repeated Mucosal SHIV Exposures and Oral Pre-Exposure Prophylaxis
    Personal Author:
    Kersh, Ellen N.; Adams, Debra R.; Youngpairoj, Ae S.; Luo, Wei.; Zheng, Qi.; Cong, Mian-er.; Aung, Wutyi.; Mitchell, James.; Otten, Ron.; Hendry, R. Michael.; Heneine, Walid.; McNicholl, Janet.; Garcia-Lerma, J. Gerardo.;
    Published:
    Apr 26 2011
    Source:
    PLoS One. 6(4).
    Description:
    Pre-exposure prophylaxis (PrEP) with anti-viral drugs is currently in clinical trials for the prevention of HIV infection. Induction of adaptive immune responses to virus exposures during anti-viral drug administration, i.e., a "chemo-vaccination" ef...
    File Type:
    Filetype[PDF - 1.14 MB]
  5. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus; Guidelines for using the quantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection
    Personal Author:
    Mazurek, Gerald H.; McDougal, J. Steven; Nicholson, Janet K. A., 1948-; Villarino, Margarita E.;
    Corporate Author:
    National Center for HIV, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.; Centers for Disease Control and Preventiom (U.S.); National Center for Infectious Diseases (U.S.); National Center for Infectious Diseases (U.S.), Division of AIDS, STD, and TB Laboratory Research.;
    Published:
    January 31, 2003
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-2
    Description:
    These guidelines were developed by CDC for laboratorians who perform immunophenotyping for detection and enumeration of CD4+ T-cells and other lymphocyte subsets in persons infected with human immunodeficiency virus (HIV). The guidelines describe sin...
    File Type:
    Filetype[PDF - 397.78 KB]